PerkinElmer (NYSE:PKI) announced today that it completed a divestiture of its applied, food and enterprise service businesses. Waltham, Massachusetts-based PerkinElmer divested these businesses to investment firm New Mountain Capital. This results in a new, high-growth life sciences and diagnostics business at PerkinElmer. According to a news release, the businesses focuses on developing and delivering novel […]
PerkinElmer Inc.
PerkinElmer rises on Street-beating Q4
PerkinElmer (NYSE:PKI) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast. The Waltham, Massachusetts-based company posted profits of $179.2 million, or $1.41 per share, on sales of $1.4 billion for the three months ended Jan. 2, 2022, for a 52.9% bottom-line slide on sales growth of 0.7%. Adjusted to […]
COVID-19 test makers say their products also detect Omicron
Abbott, BD, Hologic, PerkinElmer and Thermo Fisher are reassuring the public that their COVID-19 tests detect the Omicron variant. Discovered last week in South Africa, the new variant has enough mutations that it has raised concerns worldwide — even though it is still unknown for sure whether the mutations cause greater transmissibility or vaccine evasion. […]
PerkinElmer launches new cloud-based platform for managing workflows
PerkinElmer (NYSE:PKI) announced today that it launched its PKeye workflow monitor for remotely managing and monitoring workflows. Waltham, Massachusetts–based PerkinElmer’s cloud-based PKeye workflow monitor enables laboratory personnel to remotely handle PerkinElmer instruments and workflows in real-time through 24/7 access and visibility into laboratory operations. According to a news release, the cloud-based web design and centralized […]
Medtech M&A: The industry’s biggest mergers and acquisitions of 2021
Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]
PerkinElmer launches cloud-based research suite for pharmaceutical customers
PerkinElmer (NYSE:PKI) announced today that it launched the Signals Research suite for pharmaceutical and industrial customers. Waltham, Massachusetts-based PerkinElmer’s full cloud-based Signals Research suite, deployed on Amazon Web Services (AWS) offers a secure informatics platform with integrated, end-to-end scientific data and workflow management for pharmaceutical and industrial customers. Get the full story at our sister […]
FDA grants EUA for PerkinElmer’s combination COVID-19, flu, RSV diagnostic
PerkinElmer (NYSE:PKI) announced today that it received FDA emergency use authorization (EUA) for its PKamp respiratory panel 1 assay. Qualified laboratories can now use Waltham, Massachusetts–based PerkinElmer’s PKamp respiratory SARS-CoV-2 RT-PCR panel 1 assay to simultaneously test for several serious respiratory ailments. The assay can detect SARS-CoV-2 (the virus causing COVID-19), influenza A, influenza B […]
PerkinElmer completes $5.25B acquisition of BioLegend
PerkinElmer (NYSE:PKI) announced that it completed its acquisition of BioLegend for approximately $5.25 billion. Waltham, Mass.-based PerkinElmer looks to use the acquisition — the largest in the company’s history — to expand its life science franchise into high-growth areas including cytometry, proteogenomics, multiplex assays, recombinant proteins, magnetic cell separation and bioprocessing. The company in July announced […]
PerkinElmer announces Street-beating Q2, plans to acquire BioLegend for $5.3B
PerkinElmer (NYSE:PKI) today posted Street-beating second-quarter revenues and announced the $5.3 billion acquisition of BioLegend. The Waltham, Mass.-based company posted profits of $245.9 million, or $2.19 per share, on sales of $1.2 billion for the three months ended July 4, 2021, for a 79.3% bottom-line gain on sales growth of 51.3%. Adjusted to exclude one-time […]
MedTech 100 roundup: Industry rebounds from massive dip
The medtech industry saw its largest fall in several months last week, but it has rebounded slightly after a couple of bad weeks. A strong start to 2021 hit a skid at the end of February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It had […]
PerkinElmer completes Oxford Immunotec acquisition
PerkinElmer (NYSE:PKI) announced today that it completed its previously announced acquisition of Oxford Immunotec. Under the acquisition agreement announced in January, London-based Oxford Immunotec’s shareholders will be entitled to receive $22 for each outstanding ordinary share, with the terms of the acquisition valuing Oxford Immunotec’s entire issued and to-be-issued ordinary share capital at $591 million. Get the […]
